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Abstract: Campylobacter jejuni causes campylobacteriosis, a bacterial gastroenteritis with high 
incidence worldwide. Moreover, C. jejuni infection can trigger the polyneuropathic disorder 
denominated Guillain-Barré syndrome (GBS). The C. jejuni strains that can elicit GBS carry either 
wlaN or cgtB, coding both genes for a β-1,3-galactosyltransferase enzyme that is required for the 
production of sialylated lipooligosaccharide (LOSSIAL). We described a differential prevalence of the 
genes wlaN and cgtB in C. jejuni isolates from three different ecological niches: humans, broiler 
chickens, and wild birds. The distribution of both genes, which is similar between broiler chicken 
and human isolates and distinct when compared to the wild bird isolates, suggests a host-dependent 
distribution. Moreover, the prevalence of the wlaN and cgtB genes seems to be restricted to some 
clonal complexes. Gene sequencing identified the presence of new variants of the G- homopolymeric 
tract within the wlaN gene. Furthermore, we detected two variants of a G rich region within the cgtB 
gene, suggesting that, similarly to wlaN, the G-tract in the cgtB gene mediates the phase variation 
control of cgtB expression. Caco-2 cell invasion assays indicate that there is no evident correlation 
between the production of LOSSIAL and the ability to invade eukaryotic cells. 
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1. Introduction 
Campylobacter jejuni causes the most common bacterial food-borne disease in Europe, a 
gastroenteritis named campylobacteriosis, which can range from mild, watery to bloody diarrhea 
[1,2]. Campylobacteriosis is mostly transmitted to humans by the consumption and improper 
handling of poultry meat [3]. Wild birds play a relevant role in the C. jejuni transmission route by 
being carriers that can infect both poultry and humans [4,5]. Moreover, campylobacteriosis is the 
most frequent infection preceding Guillain-Barré syndrome (GBS), an acute polyneuropathic 
disorder [6]. The strains of C. jejuni that can potentially elicit GBS are those that produce a sialylated 
LOS (LOSSIAL), due to the well-documented molecular mimicry between the LOSSIAL and the 
saccharide component of the human GM1 ganglioside which is present in peripheral nerves [7]. 
Antibodies generated against Campylobacter LOSSIAL structures might cross-react with GM1 found in 
nerve tissue [1]. Consistently, during the acute-phase of C. jejuni-associated GBS infection, the sera 
contain high titers of antibodies against LOSSIAL that cross-react with GM1 gangliosides [8]. 
The operon responsible for the biosynthesis of LOS is highly diverse among C. jejuni isolates, 
with up to 19 different locus classes, named from A to S [9,10]. Only classes A, B, and C carry genes 
coding for a β-1,3-galactosyltransferase catalyzing the addition of a galactose molecule, which is 
required for the production of a GM1-like LOSSIAL structure [11]. Two different genes have been 
identified to encode for this enzymatic activity: cgtB (in class A and B) and wlaN (in class C) [10,12]. 
The amino acid identity between CgtB and WlaN is about 58% [12]. 
Genomic analyses revealed the presence of hypervariable sequences in C. jejuni genes coding for 
proteins involved in the biosynthesis of surface structures [13]. Most of these hypervariable sequences 
consist of short homopolymeric nucleotide tracts. The wlaN gene contains a G-tract located within 
the coding sequence, rendering the expression of the wlaN gene under phase variation control, 
presumably by a slipped-strand mechanism [12]. Three different G-tract variants have been 
described, carrying either six, eight, or nine residues [12,14]. The presence of an 8G-tract results in a 
full-length product (ON-phase), whereas either a 6G- or a 9G-tract results in truncated proteins (OFF-
phase). 
In this work, we describe the prevalence of the genes responsible for LOSSIAL production, cgtB 
and wlaN, in C. jejuni isolates from different ecological origin: humans, broiler chickens, and wild 
birds. The presence and diversity of homopolymeric G-tract regions within both LOSSIAL-related 
genes are studied. The correlation between the production of LOSSIAL and the ability to invade 
eukaryotic cells is evaluated. 
2. Materials and Methods 
2.1. Bacterial Strains and Culture Conditions 
The C. jejuni strain collection, previously described [15], is composed of 150 isolates obtained 
from faeces of three different sources: human patients suffering from symptomatic gastroenteritis (50 
isolates), broiler chickens (50 isolates), and wild birds (50 isolates). Human isolates were obtained 
from the Santa Creu i Sant Pau Hospital (Barcelona) strain collection. Broiler chicken isolates belong 
to a Campylobacter strain collection at IRTA-CReSA, collected at different slaughterhouses located in 
Barcelona, Lleida, and Tarragona (Catalonia). The wild bird samples, collected in Catalonia and 
Alboran Island, were obtained from six different species (Spatula clypeata, Ciconia ciconia, Corvus corax, 
Columba livia, Larus michahellis, and Larus audouinii). The strain 81-176 (ATCC BAA-2151) was used as 
the reference strain [13]. Complete genomes of Campylobacter jejuni strains were recovered from an 
NCBI database. 
Isolates were cultured onto Columbia blood agar (CBA) plates (Scharlau) and incubated at 42°C 
for 48 h in microaerophilic conditions (CampyGen, Oxoid), unless otherwise stated. 
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2.2. PCR Amplification 
Genomic DNA was extracted from cultures grown onto CBA plates using the InstaGene Matrix 
Kit (Bio-Rad Laboratoires). PCR reactions (PCR Master Mix x2, Thermo Scientific) were performed 
using 35 ng of DNA as a template and the presence of wlaN and cgtB genes were tested using the 
specific primers indicated in Table 1. Primers used to amplify the housekeeping gene gltA were 
included in the PCR mixtures as an internal control of the PCR reaction. Amplified fragments of wlaN 
and cgtB were purified and sequenced with the same primers that were used in the PCR reaction. 
Table 1. Primers used in this work. 
Primer Sequence 5’–3’ PCR product (bp) Reference 
cgtB-F TTAAGAGCAAGATATGAAGGT 
740 [12] 
cgtB-R GCACATAGAGAACGCTACAA 
wlaN-F TGCTGGGTATACAAAGGTTGTG 
561 [16] 
wlaN-R AGGTCCATTACCGCATACCA 
gltA-F GCCCAAAGCCCATCAAGCGGA 
141 [17] 
gltA-R GCGCTTTGGGGTCATGCACA 
2.3. Analysis of LOS 
Cell biomass from one CBA plate was resuspended in 1 ml of PBS and the OD600 of the cell 
suspension determined. After centrifugation, the cells were resuspended in Laemmli buffer, 
adjusting the final volume accordingly to the OD600 of the cell suspension (OD600 x 0.5) (whole cell 
extracts). LOS was isolated as described previously [18]. Briefly, samples were incubated at 100°C for 
10 min and centrifuged at 10,000x g for 10 min. A 50 µl aliquot of the supernatant was treated with 
proteinase K (20 mg/ml; 2 h at 65 °C). LOS samples were fractionated by 15% SDS-PAGE and 
visualized by a carbohydrate specific silver staining method [16]. LOSSIAL was detected by Western 
blot using a peroxidase-conjugated labelled cholera toxin B (HRP-CT), as previously described [12]. 
Coomasie staining of whole cell extracts was used as the loading control. 
2.4. Invasion Assay 
Adherence and invasion assays were performed using human colonic carcinoma (Caco-2) cells, 
as previously described [19]. Caco-2 cells were seeded in 24-well plates at 2 × 104 cells per well and 
incubated for 8 days at 37 °C. Bacteria, grown on CBA plates under microaerophilic conditions for 24 
h at 37 °C, were resuspended in PBS plus 1% inactivated-FBS (PBS-F) and the bacterial concentration 
was adjusted at approximately 2 × 108 cfu/ml (OD600 of 0.04). Confluent monolayers of Caco-2 cells 
were washed once with PBS and infected with 0.5 ml of the bacterial suspension. To allow bacterial 
adherence and internalization, monolayers and bacteria were incubated for 3 h at 37 °C and 5% CO2 
in a humified atmosphere. For total cell-associated bacteria (intracellular and adhered) quantification, 
the unbound bacteria were removed from cell monolayers by washing with PBS, the cells were lysed 
with 0.5 ml Triton X-100 (1%) for 10 min, and the total cell-associated bacteria was determined by 
serial dilutions on CBA plates. For intracellular bacteria quantification, infected monolayers were 
washed with PBS and incubated in 0.5 ml of fresh PBS-F with 150 ml/ml gentamycin (Sigma) to kill 
extracellular bacteria. After 2 h at 37°C, cells were washed and lysed following the same procedure 
as for the total cell-associated bacteria. The amount of both intracellular and total cell-associated 
bacteria (intracellular and adhered) was determined in triplicate assays. The invasion index was 
calculated as the percentage of intracellular bacteria relative to the total cell-associated bacteria. 
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3. Results 
3.1. Differential Prevalence of wlaN and cgtB Genes in C. jejuni Isolates from Human Patients, Broiler 
Chickens, and Wild Birds 
The presence of the wlaN and cgtB genes in a collection of 150 C. jejuni strains from human 
patients (50), broiler chickens (50), and wild birds (50) was determined by PCR. A similar percentage 
of strains were positive for LOSSIAL related genes (wlaN+ and cgtB+) among human (28%) and broiler 
chicken (22%) strains. The percentage increased to 40% among wild bird strains. Interestingly, more 
striking differences exist in the prevalence of each specific gene depending on the origin of the strains 
(Figure 1). The wlaN gene was more frequently detected among human and broiler chicken strains 
(20% and 16%, respectively) than the cgtB gene (8% and 6%, respectively). In contrast, an inverse 
distribution was found among wild bird strains, with 34% of the strains cgtB+ and only 6% wlaN+. 
Therefore, among the LOSSIAL proficient strains, the wlaN gene was responsible for the LOS 
modification in 72% of the human and broiler chicken strains, whereas the cgtB gene was responsible 
in 85% of the wild bird strains. 
 
Figure 1. Prevalence of wlaN and cgtB genes in C. jejuni strains from different origins. H, human 
patients; B, broiler chickens; W, wild birds. Statistical analyses were performed using Pearson’s chi-
squared test (R Studio software). p < 0.005 was considered statistically significant (indicated by an 
asterisk). 
3.1. The Presence of the cgtB and wlaN Genes is Associated with Certain MLST Clonal Complexes 
The phylogenetic population structure of the C. jejuni collection used in this work has previously 
been reported [15]. The most frequent clonal complexes (CC) detected were ST-21, ST-1275, ST-45, 
and ST-257, each CC with 24, 16, 13, and 12 strains, respectively. 
The LOSSIAL producing strains grouped within certain CC (Table 2). The most predominant 
clonal complex, the ST-21 CC, which was only found among human and broiler strains, showed the 
highest occurrence (78%) of LOSSIAL related genes, with 14 wlaN+ and 3 cgtB+ isolates. Remarkably, the 
three cgtB+ strains belong to the ST-883. Within the ST-1275 CC, which was only found in wild bird 
strains, 44% were LOSSIAL (3 wlaN+ and 4 cgtB+). It should be highlighted that the only three wlaN+ 
strains identified among wild bird isolates belong to this CC. 
The ST-45 CC is a multihost complex found among the three populations. However, all LOSSIAL 
strains from this clonal complex (54%) were isolated only from wild birds and they carry the cgtB 
gene. The strains belonging to the ST-257 CC, isolated from human patients and broiler chickens, 
were negative for the presence of LOSSIAL-related genes. Among the non-predominant CC (containing 
3 to 10 strains per CC), the ST-179 showed the highest percentage of LOSSIAL strains (57.5%). This CC 
was only found among wild bird strains and accordingly, all LOSSIAL strains were cgtB+. The 37.5% of 
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the ST-607 CC strains, found in humans and broiler chickens, carry LOSSIAL-related genes (1 wlaN+ 
and 2 cgtB+). None of the strains belonging to the ST-48, 61, 354, 464, and 952 CC were positive for 
LOSSIAL-related genes. 
The fact that within the same sequence type we found strains carrying different LOS 
determinants is consistent with previous studies, suggesting that the LOS locus is one of the 
hypervariable regions within the C. jejuni genome [20]. 
Table 2. Collection of C. jejuni isolated from human patients (H), broiler chikens (B), and wild birds 
(W). Strains are organized attending to their ST Clonal Complexes (ST CC) and sequence types (ST). 
S means a singlenton ST. cgtB and wlaN positive strains are indicated (black squares) and the number 
of G residues found in the G-tract is indicated. 
Strain cgtB wlaN ST-CC (ST) Strain cgtB wlaN ST-CC (ST) Strain cgtB wlaN ST-CC (ST) 
H01   S (441) H62   ST-206 (572) B45   ST-354 (354) 
H72   S (441) H68   ST-21 (19) W28   ST-354 (354) 
B44   S (441) H06  9 ST-21 (19) W54   ST-354 (354) 
H53   S (531) H11  9 ST-21 (21) W55   ST-354 (354) 
B16   S (531) H32  9 ST-21 (21) W56   ST-354 (354) 
W02 5  S (996) H52  8 ST-21 (21) B37   ST-354 (8498) 
W11   S (1261) H59  8 ST-21 (21) H61 5  ST-42 (459) 
W13   S (1343) B20  9 ST-21 (21) H58 6  ST-42 (4016) 
W23   S (1343) B36  8 ST-21 (21) H46   ST-443 (51) 
H07   S (1710) B46  8 ST-21 (21) H19   ST-443 (5799) 
B10   S (1710) H12   ST-21 (50) W12   ST-446 (3552) 
B26   S (1710) H34  9 ST-21 (50) H48   ST-45 (45) 
B35   S (1710) H35   ST-21 (50) B27   ST-45 (45) 
B02   S (2331) H66  8 ST-21 (50) B31   ST-45 (45) 
W17 5  S (2351) H73  9 ST-21 (50) W30   ST-45 (45) 
W06   S (4355) B07  8 ST-21 (50) W32 5  ST-45 (45) 
W07   S (4355) B14  8 ST-21 (50) W36 5  ST-45 (45) 
W08   S (4355) B50  10/11 ST-21 (50) W37 5  ST-45 (45) 
B39   S (7114) H37 5  ST-21 (883) W40 5  ST-45 (45) 
H33   S (8479) H60 5  ST-21 (883) W43 5  ST-45 (45) 
W53   S (8514) B06 5  ST-21 (883) W44 5  ST-45 (45) 
W05   ST-1034 (4001) B17   ST-21 (883) B42   ST-45 (137) 
W24   ST-1275 (637) H54   ST-21 (1214) B22   ST-45 (652) 
W27 5  ST-1275 (637) H08   ST-21 (3769) W47 5  ST-45 (8512) 
W03   ST-1275 (1223) H02   ST-21 (4664) H18   ST-464 (464) 
W10 5  ST-1275 (1223) H03   ST-257 (257) B08   ST-464 (464) 
W15 5  ST-1275 (1223) H50   ST-257 (257) B15   ST-464 (464) 
W18 5  ST-1275 (1223) H56   ST-257 (257) H38   ST-48 (48) 
W21   ST-1275 (1223) B52   ST-257 (367) B09   ST-48 (48) 
W22   ST-1275 (1268) B53   ST-257 (367) W29   ST-48 (48) 
W04   ST-1275 (1275) B54   ST-257 (367) H71   ST-49 (49) 
W09  5 ST-1275 (1275) B55   ST-257 (367) H51   ST-52 (52) 
W20  5 ST-1275 (1275) B56   ST-257 (367) B21   ST-574 (305) 
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W14   ST-1275 (1292) B57   ST-257 (367) B25   ST-574 (305) 
W16   ST-1275 (1292) H67   ST-257 (2254) B04 5  ST-607 (607) 
W26   ST-1275 (3049) H69   ST-257 (2254) B41 5  ST-607 (607) 
W19   ST-1275 (3629) B13   ST-257 (2254) H04   ST-607 (904) 
W25  5 ST-1275 (8511) B33   ST-283 (267) B38   ST-607 (904) 
W33   ST-179 (179) B28   ST-353 (5) B47   ST-607 (904) 
W41   ST-179 (220) B29   ST-353 (5) B24  8 ST-607 (1707) 
W34 5  ST-179 (2209) H63  9 ST-353 (353) B19   ST-607 (7110) 
W39 5  ST-179 (2209) B48   ST-353 (356) B51   ST-607 (7110) 
W46 5  ST-179 (2209) H36   ST-353 (400) H05   ST-61 (61) 
W48   ST-179 (2209) B05   ST-353 (400) H40   ST-61 (61) 
W49 5  ST-179 (2209) B18   ST-353 (400) H57   ST-61 (61) 
B49  9 ST-206 (46) B30   ST-353 (400) H65   ST-61 (61) 
H64  8 ST-206 (227) B40   ST-353 (400) H70   ST-61 (61) 
H09   ST-206 (572) H49   ST-354 (354) W50   ST-952 (8513) 
H13   ST-206 (572) H74   ST-354 (354) W51   ST-952 (8513) 
H14   ST-206 (572) B23   ST-354 (354) W52   ST-952 (8513) 
3.1. Homopolymeric G-tract variants in wlaN and cgtB genes 
As described earlier, the wlaN gene carries an intragenic homopolymeric G-tract [12]. It is 
assumed that the number of G-residues can vary after DNA replication by a slipped strand 
mechanism. It has been identified that wlaN alleles carry homolopymeric G-tract with different 
numbers of G residues. So far, G-tracts with 6, 8, and 9G-residues have been described [12,14]. From 
those, the 8G-tract variant is the only one rendering a full-length product (ON). The homopolymeric 
G-tract was characterized for all wlaN+ strains of our collection (Figure 2A,B). Variants carrying the 
previously identified 8 and 9G-tracts were found in both broiler chicken and human isolates. 
Additionally, new G-tract variants were identified during our study. In the broiler chicken isolate 
B50, the wlaN sequence reveals a mixed population, with 10G- (OFF) and 11G-tracts (ON) (Figure 
2B). Strikingly, the three unique wlaN+ isolates among the wild bird strains (W09, W20, and W25), 
belonging to the ST-1275 CC, carry a 5G-tract variant, which was not previously described (Table 2). 
Detection of LOSSIAL in extracts of the W20 strain corroborate that the newly described wlaN 5G-tract 
variant renders expression of a functional β-1,3-galactosyltransferase (Figure 2D). It is worth 
mentioning that the nucleotide sequence surrounding the G-tract has very high identity among the 
sequenced wlaN variants (Figure S1). 
It has not yet been reported whether cgtB expression is under phase variation control. 
Interestingly, the cgtB gene carries a G-tract which is located in a different relative position within 
the coding sequence as compared to wlaN. Within the wlaN coding sequence, the G-tract is located at 
position 331 from 912 nt; whereas, within the cgtB coding sequence, the newly described G-tract is 
located at position 476 from 906 nt (Figure S2). In most cgtB+ C. jejuni sequenced strains, the cgtB gene 
carries a 5G-tract, which renders a full length protein (Table 2, [21]). The length of the homopolymeric 
G-tract in the cgtB+ isolates was determined. Although most cgtB+ strains carry a 5G-tract (ON), the 
human isolate H58 carries a 6G-tract, which will generate a truncated protein (Figure 2C). These 
results suggest that the homopolymeric G-tract which is present within the cgtB gene may also be 
mediating phase variation control. As for wlaN, the sequences surrounding the G tract of the cgtB 
variants show very high identity (Figure S3). 
The phase variation control involves phenotypic diversity (LOS and LOSSIAL) within a clonal 
population. The presence of LOSSIAL on C. jejuni surface can be detected by its ability to bind cholera 
toxin subunit B (CT) [12]. Phenotypic characterization of the LOSSIAL production in wlaN+ and cgtB+ 
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strains was performed. Representative results are shown in Figure 2D and Figure 3. LOSSIAL was 
detected in all extracts from either wlaN+ or cgtB+ strains carrying “ON” G-tracts and in most of the 
genotypically “OFF” characterized strains, as in the case of H63 strain (Figure 3). Exceptionally, in 
extracts from H11 and H58 strains, carrying “OFF” G-tracts were negative for LOSSIAL detection 
(Figure 2D). LOS silver staining indicates that both strains indeed produce LOS structures, although 
it does not carry the modification recognized by the cholera toxin (Figure 2E). 
 
Figure 2. G-tract characterization within the wlaN and cgtB genes. (A) Homopolymeric G-tracts 
identified in wlaN and cgtB genes from human (H), broiler chicken (B), and wild bird strains (W). The 
different homopolymeric variants identified are indicated and the number of strains is shown 
between parentheses. (B) Sequence of the intragenic homopolymeric G-tracts (indicated by red lines) 
of the wlaN gene of the strains H11, H52, W20, and B50. The number of G residues within the G-tract 
are indicated between parentheses. (C) Sequence of the intragenic homopolymeric G-tracts (indicated 
by red lines) of the cgtB gene of the strains H58 and W27. The number of G residues within the G-
tracts are indicated between parentheses. (D) Detection of LOSSIAL in purified LOS samples from 
cultures of the indicated strains grown onto CBA plates for 48 h at 42°C. LOSSIAL was detected by 
Western blot using HRP-CT. Below, the presence for each strain of either the wlaN or cgtB gene is 
indicated and the G-tract variant detected. (E) Silver-stained 15% SDS-PAGE of the same samples of 
purified LOS as in D. (F) Coomassie-stained 15% SDS-PAGE of whole cell extracts from the cultures 
used to obtain the purified LOS samples analyzed in D and E. In E and F, the migration of the 10 and 
15 kDa proteins from the molecular mass marker are indicated. 
3.4. The production of LOSSIAL is Not Affected by Temperature 
C. jejuni colonizes different hosts, including birds as broilers and mammals as humans. The 
LOSSIAL production at 42°C and 37°C, resembling the gastrointestinal tract temperature in broiler 
chickens and humans, respectively, was monitored. No difference was detected in the amount of LOS 
in extracts from the LOSSIAL (strains B24 and H63) or non-sialylated LOS (H33) from cultures grown 
at 42 °C and 37 °C (Figure 3). 
Microorganisms 2020, 8, 325 8 of 12 
 
 
Figure 3. Analysis of LOS from C. jejuni strains grown at either 37°C or 42°C. A. Detection of LOSSIAL 
in purified LOS samples from cultures of the indicated strains grown onto CBA plates for 48 h at 
either 37°C or 42°C. LOSSIAL was detected by Western blot using HRP-CT. B. Silver-stained 15% SDS-
PAGE of the same samples of purified LOS as in A. C. Coomassie-stained 15% SDS-PAGE of whole 
cell extracts from the cultures used to obtain the purified LOS samples analyzed in A and B. In B and 
C, the migration of the 10 and 15 kDa proteins from the molecular mass marker is indicated. 
3.5. Sialylation is Not Needed for Invasiveness 
The role of LOSSIAL structures in C. jejuni pathogenicity is not fully understood. It was proposed 
that the LOSSIAL presence on the surface of C. jejuni might promote invasion of eukaryotic cells 
[14,22,23]. However, controversial data is reported by different authors [24,25]. 
The ability to invade Caco-2 cells by 38 C. jejuni strains (37 from our collection and the pathogenic 
81-176 strain) was tested. Half of the strains were LOSSIAL proficient (wlaN+ or cgtB+). The invasion 
index was calculated and the results indicate that no correlation exists between the presence of 
LOSSIAL structures and invasiveness (Figure 4). 
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Figure 4. Relation between invasion index and LOSSIAL production in C. jejuni strains. The invasion 
index was calculated as the percentage of intracellular cells from the total cell-associated bacteria after 
3 h infection of Caco-2 cells with the indicated strains. The average and standard deviation of three 
independent experiments are shown. Grey and black bars indicate strains that express or do not 
express LOSSIAL, respectively. 
4. Discussion 
The presence of LOSSIAL-related genes—wlaN and cgtB—coding for β-1,3-glycosyltransferases is 
correlated with the ability to trigger GBS in patients suffering from campylobacteriosis. In our study, 
the prevalence of these genes was determined among C. jejuni isolates from human patients and 
broiler chickens since the consumption of undercooked chicken meat is the most common 
transmission route of C. jejuni to humans. C. jejuni isolates from wild birds were also analyzed since 
circulation of C. jejuni strains among poultry and wild birds has been reported [26]. Furthermore, 
wild birds are potential sources of human campylobacteriosis [4,27]. Previous studies focused mostly 
on comparing human and broiler chicken isolates and no correlation between the origin of the strains 
and the presence of wlaN and cgtB genes was found. It has been described that 40% to 60% of human 
isolates and 28% to 90% of broiler chicken isolates carry LOSSIAL related genes [21,28–32]. Similarly, 
in our collection, no significant differences were found in the prevalence of LOSSIAL-related genes 
among human and broiler chicken isolates (28% and 22%, respectively). Remarkably, our data 
indicate that the prevalence of LOSSIAL-related genes is higher among the wild bird isolates (40%).  
Among the LOSSIAL proficient strains, a differential distribution of the cgtB and wlaN genes 
between the human/broiler chicken isolates and those from wild birds was found. The wlaN gene is 
detected in 72% of the LOSSIAL strains from humans and broiler chickens, whereas the most prevalent 
LOSSIAL-related gene in wild bird isolates is cgtB (85%). The information available on the prevalence 
of LOSSIAL-related genes among wild bird isolates is limited. No previous data exist on the prevalence 
of the cgtB gene, and the presence of the wlaN gene has been estimated between 11% and 17% of wild 
bird isolates [33,34]. Although several reports indicated that cgtB and wlaN may coexist [14,31], our 
data suggest the contrary, since none of the isolates carry both genes. 
A search for the presence of LOSSIAL-related genes among 136 C. jejuni genome sequences 
available in the NCBI database was performed (Table S1). In agreement with our data, the presence 
of LOSSIAL-related genes was confirmed in 40% of the strains, with wlaN and cgtB present in 22% and 
18%, respectively. It should be noted that 87% of LOSSIAL positive strains were isolated from human 
or broiler chicken hosts and the remaining 13% from other domestic animals. Moreover, none of the 
genome sequences were found to simultaneously carry wlaN and cgtB.  
The wlaN gene is under phase variation control [12], meaning that within a clonal population, 
cells can express sialylated and unsialylated LOS. This phenomenon is achieved since the number of 
G residues in a G-tract within the wlaN coding sequence can be randomly altered during replication, 
rendering a truncated or a fully functional protein. Three variants were previously described (6G, 8G, 
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and 9G) [12,13]. Here, we revealed three new variants: a 5G-tract found in three wild bird isolates 
and 10- and 11G-tracts, which were both found in a broiler chicken isolate (Figures 2B and S1). 
Remarkably, the cgtB gene carries a G-tract within the coding sequence, but a potential phase 
variation regulation was not reported. Here, two cgtB variants were found (Figure 2C, Figure S3): a 
5G-tract, detected in most cgtB+ strains, rendering a full protein and a 6G-tract, detected only in one 
isolate, rendering a truncated peptide. Interestingly, the genomic sequence of the well-characterized 
strain 81–176 indicates the presence of a truncated cgtB gene with a 6G-tract. Overall, our data suggest 
that, similar to the wlaN gene, cgtB is under phase variation regulation by altering the number of 
residues in the G-tract. Further studies will be required to fully characterize the mechanism behind 
the described phenomenon.  
Despite the well-established role of the cgtB and wlaN genes in triggering GBS [6], the relevance 
of these genes in the pathogenesis of C. jejuni during gastrointestinal infection remains unclear. The 
lack of thermoregulation of LOS and/or LOSSIAL suggests that its production is neither promoted nor 
repressed in a specific host temperature. Some authors reported a link between LOS sialylation and 
the ability to invade eukaryotic cells [14,22,23]. In agreement with other reports [24,25], our data 
suggest that no correlation exists between these two processes since no differences in the invasion 
index were detected between LOSSIAL and non-sialylated strains. 
Overall, our data reveal a closer relationship between human and broiler chicken isolates as 
compared to wild bird isolates, which is in agreement with the previous characterization of the strain 
collection in terms of population structure, drug resistance, and virulence factor profiling [15]. The 
differential distribution of wlaN and cgtB genes may also indicate a host-dependent distribution of 
the LOSSIAL-related genes, with wlaN positively selected among broiler chickens and consequently, 
also among human isolates, and cgtB positively selected among wild birds. 
Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, Figure S1: wlaN 
nucleotide sequence surrounding the position of G-tract in the wlaN positive strains, Figure S2: Alignment of 
wlaN and cgtB nucleotide sequences, Figure S3: cgtB nucleotide sequence surrounding the position of the G-tract 
in the cgtB positive strains, Table S1: Presence of the wlaN and cgtB genes in complete genome sequences of C. 
jejuni from the NCBI database.  
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